# Study on the Efficacy and Safety of MA-BUCY2 Conditioning in High-risk AML Patients Underwent Haplo-HSCT

> **NCT05814731** · NA · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 264 (estimated)

## Conditions studied

- Haploidentical Stem Cell Transplantation
- Conditioning

## Interventions

- **DRUG:** MA-BUCY2
- **DRUG:** BUCY2

## Key facts

- **NCT ID:** NCT05814731
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-15
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 264 (ESTIMATED)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05814731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05814731, "Study on the Efficacy and Safety of MA-BUCY2 Conditioning in High-risk AML Patients Underwent Haplo-HSCT". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05814731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*